Nwss multi-assay panel development
Ended Purchase Order Awarded Last action
- Contract number
- 75D30122P15161
- Awardee
-
GT Molecular, Inc. UEI DKH3J319XJL6
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $297,004
Award facts
- Opportunity
-
- Digital PCR Assay Panel Optimization, Design, & Construction Services Solicitation · 75D30122Q75423 · Posted Jul 30, 2022
- Contract value 100% obligated
- $297,003.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Fort Collins, CO, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | $49,500 | |
| Exercise an Option | $62,504 | |
| Original award | $185,000 |
About this award
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $297,003.74 firm-fixed-price purchase order to GT Molecular, Inc., a minority-owned, self-certified small disadvantaged business, for the development of a multi-pathogen, digital polymerase chain reaction (PCR) assay panel. The panel will be compatible with the Qiagen Qiacuity and BioRad QX digital PCR platforms and will be used by the government and its partners to test wastewater for multiple pathogens and antimicrobial resistance targets. This sole-source contract was awarded under the authority of Federal Acquisition Regulation (FAR) Part 13.106-1(b) and 10 U.S.C. 2304(c)(1), as GT Molecular is the only known vendor capable of developing this specialized assay panel for both digital PCR platforms.
Quick answers
Who was awarded contract 75D30122P15161?
75D30122P15161 was awarded to GT Molecular, Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 1, 2022.
How much is contract 75D30122P15161 worth?
The government has obligated $297,004 on 75D30122P15161.
Was contract 75D30122P15161 competed?
The extent of competition for 75D30122P15161 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award